0001437749-22-002054.txt : 20220201 0001437749-22-002054.hdr.sgml : 20220201 20220201092343 ACCESSION NUMBER: 0001437749-22-002054 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220128 FILED AS OF DATE: 20220201 DATE AS OF CHANGE: 20220201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sieger Markus CENTRAL INDEX KEY: 0001337143 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39780 FILM NUMBER: 22577173 MAIL ADDRESS: STREET 1: BEUTSTWEG 12 STREET 2: CH-8032 CITY: ZURICH STATE: V8 ZIP: 000000000 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cyclo Therapeutics, Inc. CENTRAL INDEX KEY: 0000922247 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 593029743 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6714 NW 16TH STREET, SUITE B CITY: GAINESVILLE STATE: FL ZIP: 32653 BUSINESS PHONE: 386-418-8060 MAIL ADDRESS: STREET 1: PO BOX 1180 CITY: ALACHUA STATE: FL ZIP: 32616-1180 FORMER COMPANY: FORMER CONFORMED NAME: CTD HOLDINGS INC DATE OF NAME CHANGE: 20000913 FORMER COMPANY: FORMER CONFORMED NAME: CYCLODEXTRIN TECHNOLOGIES DEVELOPMENT INC DATE OF NAME CHANGE: 19941012 4 1 rdgdoc.xml FORM 4 X0306 4 2022-01-28 0000922247 Cyclo Therapeutics, Inc. CYTH 0001337143 Sieger Markus 6714 NW 16TH STREET, SUITE B GAINESVILLE FL 32163 1 Common Stock 2022-01-28 4 A 0 4075 0 A 71689 D Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the Issuer's non-employee director compensation policy. Grant reflects director compensation for the fourth quarter of 2021. The number of shares received in lieu of cash was calculated based on the closing price of 3.62 per share of common stock on January 28, 2022. /s/ Markus Sieger 2022-01-31